ArticleCancers2021

Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer.

Guiyang Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.